A novel technique for the quality assurance of dwell positions for ovoid applicators using 2D optical imaging
Brachytherapy · 2025-09 · 24 (5) · 763-771
DOI: 10.1016/j.brachy.2025.03.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brachytherapy, 2025-09. Verfasst von Jette Borg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Center, Toronto, Ontario, Canada; University of Toronto, Department Radiation Oncology, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Quality Assurance, Health Care, Brachytherapy, Genital Neoplasms, Female, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: We propose a new method for commissioning lunar ovoid applicators in high dose rate gynecology brachytherapy based on 2D optical scintillating imaging of the applicators. METHODS: Treatment plans were generated for 22 mm and 26 mm diameter Venezia applicators, using four to eight dwell positions in each ovoid. Images of the applicator dwell positions were acquired using a pinhole apparatus combined with scintillating material and optical camera. Images were acquired for individual dwell positions and processed to identify pixel locations with peak signal intensity. Catheter dwell positions were used to register pixel locations in the optical images and absolute coordinates of the applicator in the treatment planning system. Errors were calculated using the standard deviation in the Euclidean distance between measured and expected ovoid dwell positions. Measurements were repeated three times, including repositioning the applicator on the measurement system. RESULTS: Imaging of each applicator required between 20 and 25 min for all dwell positions. Catheter registration errors were 0.14 ± 0.09 mm and 0.21 ± 0.04 mm for the 26 and 22 mm applicators, respectively. Average differences between the imaged and planned ovoid dwell positions were 0.48 ± 0.14 mm and 0.48 ± 0.16 mm for the 26 and 22 mm applicators, respectively. The maximum difference between the measured and planned ovoid positions was 0.7 mm and 1.3 mm measured for the 26 and 22 mm applicators, respectively. These uncertainties are lower than our clinical tolerance of 2.0 mm. CONCLUSIONS: 2D-Scintillating imaging of lunar ovoid applicator dwell positions is feasible, accurate and faster than previous methods used at our center.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Princess Margaret Cancer Center, Toronto, Ontario, Canada; University of Toronto, Department Radiation Oncology, Toronto, Ontario, Canada.
- Princess Margaret Cancer Center, Toronto, Ontario, Canada.
- Princess Margaret Cancer Center, Toronto, Ontario, Canada; University of Toronto, Department Radiation Oncology, Toronto, Ontario, Canada; University of Toronto, Department Medical Biophysics, Toronto, Ontario, Canada.
- Princess Margaret Cancer Center, Toronto, Ontario, Canada; University of Toronto, Department Radiation Oncology, Toronto, Ontario, Canada; University of Toronto, Department Medical Biophysics, Toronto, Ontario, Canada;…
Zitieren
APA
Borg, J., Beiki-Ardakani, A., Mohseni, H., Golshan, M., Rink, A., & Weersink, R. A. (2025). A novel technique for the quality assurance of dwell positions for ovoid applicators using 2D optical imaging. Brachytherapy, 24(5), 763-771. https://doi.org/10.1016/j.brachy.2025.03.003
Vancouver
Borg J, Beiki-Ardakani A, Mohseni H, Golshan M, Rink A, Weersink RA. A novel technique for the quality assurance of dwell positions for ovoid applicators using 2D optical imaging. Brachytherapy. 2025;24(5):763-771. doi:10.1016/j.brachy.2025.03.003
BibTeX
@article{Borg2025,
author = {Borg, Jette and Beiki-Ardakani, Akbar and Mohseni, Hedi and Golshan, Maryam and Rink, Alexandra and Weersink, Robert A},
title = {A novel technique for the quality assurance of dwell positions for ovoid applicators using 2D optical imaging},
journal = {Brachytherapy},
year = {2025},
volume = {24},
number = {5},
pages = {763--771},
doi = {10.1016/j.brachy.2025.03.003}
}
EUVIMED